Hybrid promoters directed tBid gene expression to breast cancer cells by transcriptional targeting

Biotechnology Progress
Samila FarokhimaneshBaratali Mashkani

Abstract

Developing cancer gene therapy constructs based on transcriptional targeting of genes to cancer cells is a new and promising modality for treatment of cancer. Introducing truncated Bid (tBid), a recently known member of the Bcl-2 family, eradicates cancer cells efficiently. For transcriptional targeting of tBid, two dual-specificity promoters, combining cancer specific core promoters and response modules, were designed. These two core promoter modules contained cancer specific promoters of MUC1 and Survivin genes accompanied by hypoxia-responsive elements and estrogen responsive elements (microenvironment condition of breast cancer cells) which were employed to achieve a higher and more specific level of tBid expression in breast cancer cells. Correlation of the level of tBid expression in normal and cancer cell lines with promoter activity was measured by RT-PCR after treatment with hypoxia and estrogen. The level of tBid expression under control of new hybrid promoters was compared with its expression under control of cytomegalovirus (CMV) promoter as a control. Our data revealed that the level of tBid expression in breast cancer cells were nearly 11 times more than normal cells because of the cancer specific promoters, altho...Continue Reading

References

Jan 1, 1992·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·P L DevineI F McKenzie
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P SalmonD Klatzmann
Nov 15, 1996·Genes & Development·K WangS J Korsmeyer
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·P H MaxwellP J Ratcliffe
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Aug 24, 1999·Gene Therapy·N Lemoine, J Glorioso
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H S PandhaN R Lemoine
Nov 24, 1999·The Biochemical Journal·F Li, D C Altieri
Mar 24, 2000·Trends in Genetics : TIG·D M NettelbeckR Müller
Nov 10, 2000·Advanced Drug Delivery Reviews·K J HarringtonR G Vile
Mar 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y TsurutaS Fujii
Nov 21, 2001·The Journal of Biological Chemistry·William H HoffmanMaureen Murphy
Dec 14, 2001·The Journal of Biological Chemistry·Muniswamy MadeshGyörgy Hajnóczky
Mar 20, 2002·Clinical Oncology : a Journal of the Royal College of Radiologists·Kevin J HarringtonRichard G Vile
Mar 22, 2002·Nature Reviews. Cancer·F McCormick
May 23, 2002·Biochimie·Kelvin CainGerald M Cohen
May 25, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Heidi Y ShiMing Zhang
Jul 18, 2002·Nature Reviews. Drug Discovery·Jason Y Zhang
Jul 18, 2002·Nature Reviews. Drug Discovery·John C Reed
Oct 15, 2003·Trends in Molecular Medicine·Lily WuMakoto Sato
Feb 11, 2004·Endocrine Reviews·Luisa BarzonGiorgio Palù
Sep 24, 2004·Current Gene Therapy·Maaike Everts, David T Curiel
Aug 20, 2005·Cancer Gene Therapy·I KazhdanR A Marciniak
Feb 10, 2009·Veterinary Immunology and Immunopathology·Ezequiel LacunzaMaría V Croce

❮ Previous
Next ❯

Citations

Nov 7, 2020·FEBS Open Bio·Yuanyuan DouChun-Peng Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.